Prachem Laboratories API Project Fuels Innovation in Gujarat

Prachem Laboratories Private Limited's Active Pharmaceutical Ingredients (APIs) project in Ambavpura, Mahesana, Gujarat, signifies a significant advancement in India's pharmaceutical sector. With an investment of 10 crore and a substantial production capacity of 745 Metric Tons Per Month (MTPM) of APIs, the project holds promise for the domestic pharmaceutical industry. While the specific types of APIs remain undisclosed, the high production capacity suggests a focus on in-demand or critical medications, potentially enhancing healthcare accessibility.

This project's potential benefits are far-reaching. By increasing domestic API production, it could reduce India's dependency on imported APIs, potentially lowering medication costs and broadening healthcare access. Furthermore, the initiative is expected to generate job opportunities in Mahesana, fostering economic growth in the region and fortifying Gujarat's position as a pharmaceutical hub. Additionally, this development aligns with India's goal of achieving self-reliance in pharmaceutical production, ensuring healthcare security and reducing reliance on other nations. 

As on December, 2023. The project is now in the stage of construction being started. The completion of the project's work has reached the 25% mark. The work on the project will be finished by December of 2024.      

News by Rahul Yelligetti